A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

clinical trial

A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00489151

P4135maximum age70
P1050medical conditionhepatitis BQ6853
P2899minimum age18
P1132number of participants70
P4844research interventionadefovirQ353551
lamivudineQ422631
adefovir dipivoxilQ28851735
P6153research siteQueen Mary Hospital, Hong KongQ7270465
P580start time2005-06-01
P8363study typeinterventional studyQ78089383
P1476titleA Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

Search more.